Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997;24(4):308-16.

Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease

J P Kovalchin  1 , A R Mott, K L Rosen, T F Feltes
Affiliations
Free PMC article
Review

Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease

J P Kovalchin et al. Tex Heart Inst J. 1997.
Free PMC article

Abstract

The use of inhaled nitric oxide as a selective pulmonary vasodilator has expanded to include patients with congenital heart disease and pulmonary hypertension. The therapeutic and diagnostic roles of inhaled nitric oxide offer additional alternatives and benefits to these patients with pulmonary hypertension, particularly in the postoperative setting. This article reviews the background, mechanism of action, toxicities, and current clinical applications of inhaled nitric oxide in the child with congenital heart disease and pulmonary hypertension.

PubMed Disclaimer

References

    1. J Clin Invest. 1993 Feb;91(2):379-87 - PubMed
    1. Br J Clin Pharmacol. 1993 Jul;36(1):45-9 - PubMed
    1. Circ Res. 1993 Nov;73(5):808-12 - PubMed
    1. Eur J Clin Invest. 1993 Aug;23(8):499-502 - PubMed
    1. J Am Coll Cardiol. 1994 Aug;24(2):555-66 - PubMed

MeSH terms

LinkOut - more resources